相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Prioritizing target-disease associations with novel safety and efficacy scoring methods
Mario Failli et al.
SCIENTIFIC REPORTS (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions
Heonjong Han et al.
NUCLEIC ACIDS RESEARCH (2018)
Network perturbation analysis of gene transcriptional profiles reveals protein targets and mechanism of action of drugs and influenza A viral infection
Heeju Noh et al.
NUCLEIC ACIDS RESEARCH (2018)
InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment
Masaru Koido et al.
Oncotarget (2018)
Capturing context-specific regulation in molecular interaction networks
Stephen T. A. Rush et al.
BMC BIOINFORMATICS (2018)
Network-Guided Discovery of Influenza Virus Replication Host Factors
Emily E. Ackerman et al.
MBIO (2018)
Drug-Target Interaction Prediction via Dual Laplacian Graph Regularized Matrix Completion
Minhui Wang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Drug Target Protein-Protein Interaction Networks: A Systematic Perspective
Yanghe Feng et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Clinical trial research in focus: why do so many clinical trials fail in IPF?
Paolo Spagnolo et al.
LANCET RESPIRATORY MEDICINE (2017)
STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2016)
Inferring gene targets of drugs and chemical compounds from gene expression profiles
Heeju Noh et al.
BIOINFORMATICS (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Changing R&D models in research-based pharmaceutical companies
Alexander Schuhmacher et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases
Daniel Marbach et al.
NATURE METHODS (2016)
Phase II and phase III failures: 2013-2015
Richard K. Harrison
NATURE REVIEWS DRUG DISCOVERY (2016)
Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
Thomas J. Hwang et al.
JAMA INTERNAL MEDICINE (2016)
How Good Is Evidence from Clinical Studies of Drug Effects and Why Might Such Evidence Fail in the Prediction of the Clinical Utility of Drugs?
Huseyin Naci et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Elucidating Compound Mechanism of Action by Network Perturbation Analysis
Jung Hoon Woo et al.
CELL (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse
Zhi-Ping Liu et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2015)
Drug target prioritization by perturbed gene expression and network information
Zerrin Isik et al.
SCIENTIFIC REPORTS (2015)
Identifying problematic drugs based on the characteristics of their targets
Tiago J. S. Lopes et al.
FRONTIERS IN PHARMACOLOGY (2015)
CellNet: Network Biology Applied to Stem Cell Engineering
Patrick Cahan et al.
CELL (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
A community computational challenge to predict the activity of pairs of compounds
Mukesh Bansal et al.
NATURE BIOTECHNOLOGY (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Transcriptional data: a new gateway to drug repositioning?
Francesco Iorio et al.
DRUG DISCOVERY TODAY (2013)
Finding the targets of a drug by integration of gene expression data with a protein interaction network
Griet Laenen et al.
MOLECULAR BIOSYSTEMS (2013)
Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
Dorothea Emig et al.
PLOS ONE (2013)
Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers
Edward Y. Chen et al.
BIOINFORMATICS (2012)
Causal reasoning on biological networks: interpreting transcriptional changes
Leonid Chindelevitch et al.
BIOINFORMATICS (2012)
Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks
Florian Martin et al.
BMC SYSTEMS BIOLOGY (2012)
A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo
C. Magkoufopoulou et al.
CARCINOGENESIS (2012)
What makes a good drug target?
Isabella Gashaw et al.
DRUG DISCOVERY TODAY (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells
Stefan Kubicek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Discovering the Targets of Drugs Via Computational Systems Biology
Hon Nian Chua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Modulatory profiling identifies mechanisms of small molecule-induced cell death
Adam J. Wolpaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Steven M. Paul et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
KEA: kinase enrichment analysis
Alexander Lachmann et al.
BIOINFORMATICS (2009)
The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network
Mingzhu Zhu et al.
JOURNAL OF DRUG TARGETING (2009)
Predicting gene targets of perturbations via network-based filtering of mRNA expression compendia
Elissa J. Cosgrove et al.
BIOINFORMATICS (2008)
STITCH: interaction networks of chemicals and proteins
Michael Kuhn et al.
NUCLEIC ACIDS RESEARCH (2008)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action
B Ganter et al.
JOURNAL OF BIOTECHNOLOGY (2005)
Chemogenomic profiling on a genomewide scale using reverse-engineered gene networks
D di Bernardo et al.
NATURE BIOTECHNOLOGY (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Inferring genetic networks and identifying compound mode of action via expression profiling
TS Gardner et al.
SCIENCE (2003)
分享论文
